Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma.

J Immunother Cancer · 2022 · PMC8753436 · PMID 35017147

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The numbers of intratumoral CD4 + T cells were heterogeneous and showed a trend but no significant increase in the group vaccinated with Qβ(1668)-NeoAG L ( figure 5E , bottom, and online supplemental figure 6 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.